Further investigations are needed to assess how these associations correspond with disease risk and health outcomes. Our initial assessments found a positive association with HDLC values in men, women, and children, consistent with findings from other studies (1). Thus, the observed pattern could be explained in part by the increased use of androgen therapy. This pattern has not been observed in previous NHANES cycles and other study populations, which reported a consistent decline in totalT values with increasing age in men (10, 29). From there, your clinician recommends a starting trt dosage and follow-up labs to fine-tune the trt dose. A proper TRT plan starts with objective testing (usually morning total testosterone, often with free testosterone and SHBG), a review of symptoms, and discussion of benefits and risks. In simple terms, it replaces the testosterone your body is not producing in sufficient amounts, aiming to relieve symptoms like low energy, decreased libido, or reduced muscle mass. TRT is a doctor-prescribed treatment for confirmed low testosterone (hypogonadism). Along the way, we’ll address common questions such as what is a normal weekly dose of testosterone and how often injections are given. Your ideal plan depends on diagnosis, symptoms, blood test results, and how you metabolize medication over time. This guide explains how clinicians set and adjust TRT dosing using a practical testosterone injection dosage chart. Measuring testosterone levels became easier in the 1970s, and it wasn't long before levels were being checked in men across all age groups. Total levels of testosterone in the body have been reported as 264 to 916 ng/dL (nanograms per deciliter) in non-obese European and American men age 19 to 39 years, while mean testosterone levels in adult men have been reported as 630 ng/dL. When testosterone levels are low, gonadotropin-releasing hormone (GnRH) is released by the hypothalamus, which in turn stimulates the pituitary gland to release FSH and LH. Higher pre-natal testosterone indicated by a low digit ratio as well as adult testosterone levels increased risk of fouls or aggression among male players in a soccer game. The masculinization of the brain is not just mediated by testosterone levels at the adult stage, but also testosterone exposure in the womb. The same research found fathers (outside competitive environments) had the lowest testosterone levels compared to other males. It is unclear if the use of testosterone for low levels due to aging is beneficial or harmful. Decline of testosterone production with age has led to interest in androgen replacement therapy. In people who have undergone testosterone deprivation therapy, testosterone increases beyond the castrate level have been shown to increase the rate of spread of an existing prostate cancer. The brain is also affected by this sexual differentiation; the enzyme aromatase converts testosterone into estradiol that is responsible for masculinization of the brain in male mice. Adult testosterone effects are more clearly demonstrable in males than in females, but are likely important to both sexes. Interventions are common if hematocrit approaches about 54%, and clinicians individualize prostate monitoring by age and risk (summarized in the AUA Testosterone Deficiency Guideline). Most start conservatively, reassess at 3–6 months, and adjust by small increments (e.g., 10–20 mg/week) while watching hematocrit, PSA, blood pressure, and lipids. Because vials come in different concentrations (commonly 100 mg/mL or 200 mg/mL), "1 mL" can mean 100 mg or 200 mg depending on the product. Decisions at this level should be made with a clinician who is monitoring labs at appropriate intervals (see cautions across the AUA guideline and dosing context in the Drugs.com monograph). This is why guidelines anchor dosing changes to timed labs plus symptoms, not to a predicted math outcome (summarized in the Endocrine Society guideline). After 3–6 months, your team reviews symptoms and labs, then moves up or down in small increments. This approach aligns with the pharmacokinetics of short esters and with guideline emphasis on individualized titration rather than a one-size-fits-all number (see practical dosing notes on Mayo Clinic’s IM/SC page). Cleveland Clinic’s health articles are based on evidence-backed information and review by medical professionals to ensure accuracy, reliability and up-to-date clinical standards. Testosterone deficiency during fetal development doesn’t allow male characteristics to develop normally. This condition is very common — up to 15% of females of reproductive age have it. For adult females, testosterone enhances libido. The 2-hour ambulatory serum T level after T gel application was neither a good indicator of timed serum T concentration nor Cavg with the same dose on another inpatient day. Our data demonstrate the limitations of using ambulatory T levels to reflect either a timed serum T concentration or Cavg over a 24-hour period in an inpatient setting and suggest that dose adjustment based on a single ambulatory sample will not predictably bring 24-hour serum T levels within a narrow desired target range. These data indicate that postgel application serum T concentrations during ambulatory visits do not reflect serum T levels when participants in a clinical trial are confined to a research unit with a controlled environment and standardized medical center-provided meals. There are no prior reports of how well timed 2-hour post-T gel application serum T levels during two different inpatient days with multiple sampling for the PK study correlate with each other, but Cavg, Cmax, and Cmin were reported to be very similar on the two different sampling days (15, 18). Prior studies in younger hypogonadal men (mean age 51 y) using the same T gel formulation (Androgel 1% III) for 180 days showed that the average fluctuation index ranged from 86% after 90 days of T gel application (dose ranging from 5 to 10 g/d of gel) to about 60% at baseline (15), similar to the results in older men in the current study. Testosterone is used as a medication for the treatment of male hypogonadism, gender dysphoria, and certain types of breast cancer. In androgen-deficient men with concomitant autoimmune thyroiditis, substitution therapy with testosterone leads to a decrease in thyroid autoantibody titres and an increase in thyroid's secretory capacity (SPINA-GT). As demonstrated by a meta-analysis, substitution therapy with testosterone results in a significant reduction of inflammatory markers. Conflicting results have been obtained concerning the importance of testosterone in maintaining cardiovascular health. Specifically, testosterone, along with anti-Müllerian hormone (AMH) promote growth of the Wolffian duct and degeneration of the Müllerian duct respectively. In addition to its role as a natural hormone, testosterone is used as a medication to treat hypogonadism and breast cancer. have been undertaken on the relationship between more general aggressive behavior, and feelings, and testosterone. Nearly all studies of juvenile delinquency and testosterone are not significant. On the other hand, elevated testosterone in men may increase their generosity, primarily to attract a potential mate. Men who produce less testosterone are more likely to be in a relationship or married, and men who produce more testosterone are more likely to divorce.|You may also want to take a testosterone test if you’re experiencing symptoms of low or high testosterone. In females, testosterone is produced in much lesser quantities in the ovaries, adrenal glands, and fat cells. The ACP also suggests that clinicians consider prescribing IM testosterone rather than transdermal formulations because of their similar efficacy at a lower cost.31 However, EAU guidelines suggest that short-acting formulations may be better for adjusting the dosage should AEs occur.14,56 Clinicians should not initiate testosterone in men with age-related low testosterone to improve energy, vitality, physical function, or cognition. Among the specific populations are younger patients and others who wish to maintain fertility, patients with a history of CV disease, those with concerns about polycythemia, those aged 65 years and older, those with obesity or type 2 diabetes, those with a high risk of prostate cancer, those with OSA, and transgender and gender-diverse patients. EPotentially reversible functional causes of secondary hypogonadism include hyperthyroidism, hyperprolactinemia, growth hormone deficiency, adrenal insufficiency, obstructive sleep apnea, anemia, vitamin D deficiency, obesity, CVD, diabetes mellitus, depression, anxiety, bipolar disorder, adjustment disorder, heart failure, HIV, chronic kidney disease, cirrhosis, neoplasm, and use of beta blockers, antidepressants, opioids, and anabolic steroids.|As the metabolism of testosterone in males is more pronounced, the daily production is about 20 times greater in men. In humans and most other vertebrates, testosterone is secreted primarily by the testicles of males and, to a lesser extent, the ovaries of females. In summary, we quantified totalT concentrations in children, men, and women in a representative, cross-sectional sample of the noninstitutionalized US population for the years 2011 and 2012, including NHAs. The study design and the information collected in the 2011–2012 NHANES is insufficient to appropriately define clinical decision levels or explain in detail the underlying causes of our observations. Smokers showed higher totalT concentrations than non-smokers in both men and women.|Covariate-adjusted totalT values in men were higher at age 55–60 years compared to ages 35 and 80 years, a pattern different from that observed in previous NHANES cycles. The 10th–90th percentiles of totalT values in adults (≥20 years) was 150–698 ng/dL (5.20–24.2 nmol/L) in men, 7.1–49.8 ng/dL (0.25–1.73 nmol/L) in women, and 1.0–9.5 ng/dL (0.04–0.33 nmol/L) in children (6–10 years old). This is how we empower men to reach their peak health and live with confidence. If your goals are primarily cosmetic or competitive, discuss safer alternatives (training periodization, nutrition, sleep, and legal supplements) with a qualified professional rather than pursuing non-medical hormone use. That context underscores why dosing in TRT is individualized and monitored—and why using "trt dosage" concepts to construct a bodybuilding plan is inappropriate and potentially dangerous.}